Two schedules of oral topotecan for Myelodysplastic Syndrome (MDS)-CALGB Study 19803
Contribuinte(s) |
Daniel G. Haller Ken G. Kornfield |
---|---|
Data(s) |
01/01/2001
|
Identificador | |
Idioma(s) |
eng |
Publicador |
American Society of Clinical Oncology |
Palavras-Chave | #EX #320503 Clinical Pharmacology and Therapeutics #730108 Cancer and related disorders |
Tipo |
Conference Paper |